AU2002325466A1 - The antibody directed against the hiv strain type o, the hybridoma cell line producing it and the uses thereof - Google Patents
The antibody directed against the hiv strain type o, the hybridoma cell line producing it and the uses thereofInfo
- Publication number
- AU2002325466A1 AU2002325466A1 AU2002325466A AU2002325466A AU2002325466A1 AU 2002325466 A1 AU2002325466 A1 AU 2002325466A1 AU 2002325466 A AU2002325466 A AU 2002325466A AU 2002325466 A AU2002325466 A AU 2002325466A AU 2002325466 A1 AU2002325466 A1 AU 2002325466A1
- Authority
- AU
- Australia
- Prior art keywords
- cell line
- directed against
- hybridoma cell
- antibody directed
- line producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000004408 hybridoma Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN02125371.4 | 2002-07-29 | ||
CNB021253714A CN1238499C (en) | 2002-07-29 | 2002-07-29 | Antibody against AIDS virus O and its production cell series and use |
PCT/CN2002/000551 WO2004011633A1 (en) | 2002-07-29 | 2002-08-09 | The antibody directed against the hiv strain type o, the hybridoma cell line producing it and the uses thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2002325466A8 AU2002325466A8 (en) | 2004-02-16 |
AU2002325466A1 true AU2002325466A1 (en) | 2004-02-16 |
Family
ID=30121233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002325466A Abandoned AU2002325466A1 (en) | 2002-07-29 | 2002-08-09 | The antibody directed against the hiv strain type o, the hybridoma cell line producing it and the uses thereof |
Country Status (3)
Country | Link |
---|---|
CN (1) | CN1238499C (en) |
AU (1) | AU2002325466A1 (en) |
WO (1) | WO2004011633A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5459060A (en) * | 1989-08-24 | 1995-10-17 | Bioclonetics Incorporated | Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) |
DE19809785C2 (en) * | 1998-03-08 | 2000-02-10 | Wolfgang Bergter | Radioimmune drug for the treatment of HIV-1 infection |
-
2002
- 2002-07-29 CN CNB021253714A patent/CN1238499C/en not_active Expired - Fee Related
- 2002-08-09 AU AU2002325466A patent/AU2002325466A1/en not_active Abandoned
- 2002-08-09 WO PCT/CN2002/000551 patent/WO2004011633A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2002325466A8 (en) | 2004-02-16 |
CN1472313A (en) | 2004-02-04 |
WO2004011633A1 (en) | 2004-02-05 |
CN1238499C (en) | 2006-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003294200A1 (en) | Ternary and quaternary nanocrystals, processes for their production and uses thereof | |
AU2003260342A1 (en) | Spirobifluorene derivatives, their preparation and uses thereof | |
WO2004029207A3 (en) | Optimized fc variants and methods for their generation | |
AU2003227481A1 (en) | Solid electrolyte, photoelectric converter and process for producing the same | |
AU2003293757A1 (en) | Novel substituted imidazo-pyridinones and imidazo-pyridazeiones, the production and use thereof as medicaments | |
AU2003216058A1 (en) | Mammalian neural stem cells, compositions and uses thereof | |
AU2003286867A1 (en) | E.x.o. rimwear | |
AU2003273249A1 (en) | Laminate structures, methods for production thereof and uses therefor | |
AU2002366467A1 (en) | Diffusion film, electrode having the diffusion film, and process for producing diffusion film | |
AU2003254864A1 (en) | Novel triarylamine polymer, process for producing the same, and use thereof | |
AU2002345758A1 (en) | Renewable, carbohydrate based co2-philes | |
AU2001241107A1 (en) | Adhesive, process for producing layered product with the adhesive, and layered product | |
AU2003295870A1 (en) | Membrane for fuel cell, and fuel cell incorporating that membrane | |
AU2003225976A1 (en) | Anti-tnf antibodies, compositions, methods and uses | |
AU2003251789A1 (en) | Metal matrix composites, and methods for making the same | |
AU2003242451A1 (en) | Polymeric laminates, processes for producing the same, and use thereof | |
AU2003237332A1 (en) | Anti-relp fusion antibodies, compositions, methods and uses | |
AU2003217565A1 (en) | Polydioxaborines, their monomers and their preparation | |
AU2003219696A1 (en) | Sga-1m, a cancer associated antigen, and uses thereof | |
AU2003300262A1 (en) | Phthalimidylazo dyes, processes for the preparation thereof and the use thereof | |
AU2003248844A1 (en) | Metal matrix composites, and methods for making the same | |
AU2003292099A1 (en) | Iron-nickel-cobalt alloy, method for the production and use thereof | |
WO2003020767A3 (en) | Antibodies against caspase-8, their preparation and use | |
AU2002325466A1 (en) | The antibody directed against the hiv strain type o, the hybridoma cell line producing it and the uses thereof | |
AU2003223992A1 (en) | Solid stabilizer composition, the production and the use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase | ||
TH | Corrigenda |
Free format text: IN VOL 18, NO 12, PAGE(S) 3436 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME TSINGHUA UNIVERSITY, APPLICATION NO. 2002325466, UNDER INID (71) CORRECT THE NAME TO READ BEIJING QINGDA YINGHUA BIO-TECH CO., LTD.; TSINGHUA UNIVERSITY |